Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals AMPH
$ 39.31 -0.2%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Amphastar Pharmaceuticals Balance Sheet 2011-2024 | AMPH

Annual Balance Sheet Amphastar Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

463 M -80.3 M -48.8 M -57 M -26.6 M -36.1 M -18.4 M -34.6 M -25 M -24.1 M -21.4 M -12.2 M -

Long Term Debt

603 M 72.8 M 74.8 M 34.2 M 39.4 M 32 M 40.8 M 32.4 M 30.2 M 36.1 M 10.1 M 16 M -

Long Term Debt Current

3.91 M 3 M 2.98 M 3.36 M 3.18 M - - - - - - - -

Total Non Current Liabilities

- - - - 69.4 M 42.4 M 50.1 M 37.9 M 34.7 M 44.9 M 21.8 M 24 M -

Total Current Liabilities

225 M 94.9 M 104 M 112 M 90 M 107 M 67.2 M 60.6 M 60 M 62.6 M - - -

Total Liabilities

873 M 213 M 226 M 183 M 159 M 149 M 117 M 98.5 M 94.6 M 108 M 87.2 M 84 M -

Deferred Revenue

- - - - - - - - 643 K 14 M 643 K 642 K -

Retained Earnings

409 M 272 M 180 M 118 M 116 M 67.5 M 76.2 M 70.9 M 60.3 M 63.1 M 73.8 M 61.9 M -

Total Assets

1.51 B 742 M 672 M 631 M 587 M 514 M 455 M 428 M 390 M 389 M 339 M 317 M -

Cash and Cash Equivalents

144 M 156 M 127 M 94.5 M 73.7 M 86.3 M 65.6 M 72.4 M 66.1 M 67.8 M 53.6 M 50.2 M -

Book Value

639 M 529 M 446 M 449 M 428 M 364 M 337 M 329 M 296 M 282 M 252 M 233 M -

Total Shareholders Equity

639 M 529 M 446 M 449 M 381 M 332 M 337 M 329 M 296 M 282 M 252 M 233 M -

All numbers in USD currency

Quarterly Balance Sheet Amphastar Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

596 M 587 M 590 M 653 M - 72.9 M 72.8 M - 73.9 M 74.3 M 74.8 M 75.6 M 30.5 M 32.3 M 45.9 M 34.2 M 34.2 M 34.2 M 46.3 M 39.4 M 39.4 M 39.4 M 49.1 M 32 M 32 M 32 M 45.7 M 40.8 M 40.8 M 40.8 M 36 M 32.4 M 32.4 M 32.4 M 40.3 M 30.2 M 30.2 M 30.2 M 42.7 M 36.1 M 36.1 M 36.1 M 10.1 M 10.1 M 10.1 M - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

818 M 778 M 873 M 949 M - 225 M 213 M - 224 M 237 M 226 M 222 M 199 M 195 M 183 M 183 M 183 M 183 M 159 M 159 M 159 M 159 M 149 M 149 M 149 M 149 M 117 M 117 M 117 M 117 M 98.5 M 98.5 M 98.5 M 98.5 M 94.6 M 94.6 M 94.6 M 94.6 M 108 M 108 M 108 M 108 M 87.2 M 87.2 M 87.2 M - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 830 K 1.66 M 643 K 643 K 643 K 643 K 643 K 14 M 14 M - - - - - - - - - - - - - -

Retained Earnings

531 M 490 M 409 M 373 M - 298 M 272 M - 222 M 205 M 180 M 161 M 131 M 123 M 118 M 118 M 118 M 118 M 116 M 116 M 116 M 116 M 67.5 M 67.5 M 67.5 M 67.5 M 72.6 M 72.6 M 76.2 M 76.2 M 70.9 M 70.9 M 70.9 M 70.9 M 60.3 M 60.3 M 60.3 M 60.3 M 63.1 M 63.1 M 63.1 M 63.1 M 73.8 M 73.8 M 73.8 M - - - - - - - - -

Total Assets

1.55 B 1.49 B 1.51 B 1.54 B - 774 M 742 M - 724 M 716 M 672 M 652 M 666 M 646 M 631 M 631 M 631 M 631 M 587 M 587 M 587 M 587 M 514 M 514 M 514 M 514 M 451 M 451 M 455 M 455 M 428 M 428 M 428 M 428 M 390 M 390 M 390 M 390 M 389 M 389 M 389 M 389 M 339 M 339 M 339 M - - - - - - - - -

Cash and Cash Equivalents

192 M 190 M 144 M 271 M 151 M 177 M 156 M 157 M 166 M 173 M 126 M 107 M 125 M 102 M 94.5 M 92.6 M 92.6 M 92.6 M 73.7 M 73.7 M 73.7 M 73.7 M 86.3 M 86.3 M 86.3 M 86.3 M 65.6 M 65.6 M 65.6 M 65.6 M 72.4 M 72.4 M 72.4 M 72.4 M 66.1 M 66.1 M 66.1 M 66.1 M 67.8 M 67.8 M 67.8 M 67.8 M 53.6 M 53.6 M 53.6 M - 50.2 M - - - 53.7 M - - -

Book Value

728 M 713 M 639 M 595 M - 549 M 529 M - 499 M 480 M 446 M 430 M 467 M 451 M 449 M 449 M 449 M 449 M 428 M 428 M 428 M 428 M 364 M 364 M 364 M 364 M 334 M 334 M 337 M 337 M 329 M 329 M 329 M 329 M 296 M 296 M 296 M 296 M 282 M 282 M 282 M 282 M 252 M 252 M 252 M - - - - - - - - -

Total Shareholders Equity

728 M 713 M 639 M 595 M 589 M 549 M 529 M 505 M 499 M 480 M 446 M 430 M 467 M 451 M 449 M 402 M 402 M 402 M 381 M 381 M 381 M 381 M 332 M 332 M 332 M 332 M 334 M 334 M 337 M 337 M 329 M 329 M 329 M 329 M 296 M 296 M 296 M 296 M 282 M 282 M 282 M 282 M 252 M 252 M 252 M - 233 M - - - 209 M - - -

All numbers in USD currency